Success Story: With NAILG’s Guidance, a Biomedical Researcher from China Successfully Secures NIW Approval
Client’s Testimonial:
“Working with NAILG was a great experience. The team was responsive and professional, and the process was much easier than I expected. Highly recommended!”
On March 14th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Researcher in the Field of Biomedical Science (Approval Notice).
General Field: Biomedical Science
Position at the Time of Case Filing: Researcher
Country of Origin: China
State of Residence at the Time of Filing: California
Approval Notice Date: March 14th, 2025
Processing Time: 1 year, 3 months, 21 days
Case Summary:
Supporting exceptional researchers in securing NIW approval is a cornerstone of our work at NAILG. One of our recent success stories features a biomedical scientist whose pioneering work in structural biology and drug discovery has made a lasting impact on the field.
His research delves into the three-dimensional structures of proteins to identify critical features that facilitate the development of innovative antibodies and small-molecule inhibitors. By examining human membrane proteins linked to rare diseases, he enhances targeted treatment strategies. His work involves producing and purifying these proteins using mammalian host cells, utilizing cryo-electron microscopy for high-precision structural determination, and conducting biochemical and cellular studies to analyze their functions. This research is instrumental in advancing treatments for infectious diseases, cancer, and rare conditions.
His contributions to the field are widely recognized:
- Published eight peer-reviewed journal articles (including one as the first author) and authored one first-authored preprint.
- Accumulated 143 citations, highlighting the significance of his work within the biomedical community.
- His research has received funding from the National Institutes of Health and the Welch Foundation.
Beyond his studies, he has provided independent researchers worldwide with valuable methodologies for tackling complex biomedical challenges. His insights have greatly enhanced the understanding of human membrane proteins, driving progress in targeted therapies.
By effectively demonstrating his achievements and the national importance of his research, we built a compelling case for his NIW petition. His work continues to propel advancements in drug development and disease treatment, reinforcing its critical role in biomedical science. His NIW approval underscores the significance of scientific innovation in shaping the future of medicine. We are honored to have supported his journey and look forward to seeing his continued contributions to the field.

